eBioMedicine: Challenging Conventional Wisdom — Bradykinesia in Parkinson’s Disease Not Driven by Beta Oscillations Alone

Deep Dive into Medical Evidence: DeepEvidence Supports Your Decision-Making   The motor symptoms of Parkinson's disease (PD) have long been considered closely related to abnormal beta oscillations in the subthalamic nucleus (STN), a notion that has become the core biomarker for current adaptive deep brain stimulation (DBS). However, a joint research team from the University of Oxford and the University of California, San Francisco, through 1046 hours of chronic cortex-STN recordings, has for the first time revealed that dynamic neural states are the key factors determining the severity of motor symptoms, opening up a new direction for the precise treatment of Parkinson's disease.     The study included five Parkinson's disease patients who received bilateral Medtronic Summit RC+S neural interface implants, with an average age of 49 years and a disease duration of 4-19 years. The researchers simultaneously recorded the neural signals from the motor cortex and STN of the patients and continuously quantified the severity of bradykinesia, tremor, and dyskinesia using wrist-worn PKG sensors. Unlike traditional static spectral analysis, the research team used a four-state hidden Markov model (HMM) to decompose continuous EEG signals into neural states with unique spectral and temporal characteristics, thereby capturing the dynamic changes in brain networks. This method overcomes the limitations of time averaging and can distinguish between different brain network configurations at different times, resolving the paradox of "the same clinical symptoms corresponding to different spectral features" that traditional analyses could not explain.   Figure:

Go to the app to view the comment content

0 0 Report